StonvexLoading…
StonvexStonvexStonvexCore line items from CNP's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $2.98B | $9.34B | $6.90B | $4.91B |
Operating Income | $658.00M | $2.11B | $1.57B | $1.07B |
Net Income | $316.00M | $1.05B | $788.00M | $495.00M |
EPS (Diluted) | $0.48 | $1.60 | $1.20 | $0.76 |
Total Assets | $47.84B | $46.53B | $45.05B | $44.10B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $639.00M | $38.00M | $37.00M | $93.00M |
Free Cash Flow OCF − CapEx | $-916.00M | $-2.38B | $-1.68B | $-1.20B |
Shares Outstanding | 654.16M | 652.87M | 652.87M | 652.81M |